| Renin angiotensin system genes are biomarkers for personalized treatment of acute myeloid leukemia with Doxorubicin as well as etoposide S Turk, C Turk, MW Akbar, B Kucukkaraduman, M Isbilen, ... PLoS One 15 (11), e0242497, 2020 | 24 | 2020 |
| TKI-related platelet dysfunction does not correlate with bleeding in patients with chronic phase-chronic myeloid leukemia with complete hematological response Y Sener, M Okay, S Aydin, Y Buyukasik, F Akbiyik, ZG Dikmen Clinical and Applied Thrombosis/Hemostasis 25, 1076029619858409, 2019 | 18 | 2019 |
| Incidence and risk factors for hepatic sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation: A retrospective multicenter study of Turkish … N Soyer, M Gunduz, E Tekgunduz, B Deveci, H Ozdogu, HH Sahin, ... Transfusion and Apheresis Science 59 (4), 102827, 2020 | 14 | 2020 |
| Predictive factors for stem cell mobilization failure in multiple myeloma patients: a single center experience H Goker, R Ciftciler, H Demiroglu, M Turgut, N Sayınalp, IC Haznedaroglu, ... Transfusion and Apheresis Science 59 (1), 102595, 2020 | 14 | 2020 |
| The impact of JAK/STAT inhibitor ruxolitinib on the genesis of lymphoproliferative diseases C Türk, M Okay, S Türk, ES Temirci, O JAWAD, S Aksu, N SAYINALP, ... Turkish Journal of Medical Sciences 49 (2), 661-674, 2019 | 10 | 2019 |
| The impact of At1r inhibition via losartan on the anti-leukaemic effects of doxorubicin in acute myeloid leukaemia M Ghasemi, M Okay, S Turk, R Naeemaee, E Guver, UY Malkan, S Aksu, ... Journal of the Renin-Angiotensin-Aldosterone System 20 (2), 1470320319851310, 2019 | 9 | 2019 |
| Leukemic stem cells shall be searched in the bone marrow before “tyrosine kinase inhibitor‐discontinuation” in chronic myeloid leukemia O Ilhan, Z Narli Ozdemir, K Dalva, A Arslan, M Okay Ozgeyik, S Ipek, ... International Journal of Laboratory Hematology 43 (5), 1110-1116, 2021 | 8 | 2021 |
| Protein kinases in hematological disorders M Okay, IC Haznedaroglu Protein Kinase-mediated Decisions Between Life and Death, 383-393, 2021 | 7 | 2021 |
| Mitoxantrone-melphalan conditioning regimen for autologous stem cell transplantation in relapsed/refractory lymphoma M Okay, Y BÜYÜKAŞIK, H Demiroğlu, ÜY Malkan, R Ciftciler, ... Turkish Journal of Medical Sciences 49 (4), 985-992, 2019 | 6 | 2019 |
| Ankaferd hemostat affects etoposide resistance of the malignant melanoma cells M Ghasemi, O Mufide, UY Malkan, T Seyhan, J Jabbar, H Hocaoglu, ... International Journal of Hematology and Oncology 33 (2), 043-053, 2020 | 5 | 2020 |
| Patterns of Hydroxyurea Prescription and Use in Routine Clinical Management of Polycythemia Vera: A Multicenter Chart Review Study Y Büyükaşık, R Ali, M Turgut, G Saydam, AS Yavuz, A Ünal, MC Ar, ... Turkish Journal of Hematology 37 (3), 177, 2020 | 4 | 2020 |
| Retrospective evaluation of chromosome 1 anomalies in hematologic malignancies: A single center study S Bozkurt, M Okay, F Sağlam, İC Haznedaroğlu Genetics & Applications 3 (3), 17-24, 2019 | 4 | 2019 |
| Mantle cell lymphoma: a Turkish Multi-Center Study M Okay, O Meletli, E Kelkitli, UY Malkan, M Turgut, Y Buyukasik, F Tekin, ... J BUON 24, 2084-9, 2019 | 4 | 2019 |
| Excellent response to bortezomib in a patient with widespread ulcerative pyoderma gangrenosum accompanied by pulmonary involvement and IgA monoclonal gammopathy E Bostan, SD Günaydın, A Karaduman, SE Evans, G Elçin, D Gülseren, ... International Wound Journal 16 (4), 1052, 2019 | 4 | 2019 |
| Splenic marginal zone lymphoma in Turkey: association with hepatitis B instead of hepatitis C virus as an etiologic and possible prognostic factor-A multicenter cohort study M Okay, T Aslan, E Özdemir, A Üner, A Sağlam, E Güngör, A Uysal, ... Turkish Journal of Hematology 37 (2), 84, 2020 | 3 | 2020 |
| Effect of postremission high dose cytarabine-based consolidation chemotherapy before allogenic stem cell transplantation in outcomes of acute myeloid leukemia patients R Ciftciler, H Demiroglu, Y Buyukasık, M Okay, S Aksu, N Sayınalp, ... Transfusion and Apheresis Science 57 (6), 752-755, 2018 | 3 | 2018 |
| Efficacy and safety of ibrutinib therapy in patients with chronic lymphocytic leukemia: retrospective analysis of real-life data A Tombak, FP Tanrıkulu, SS Durusoy, HD Dinçyürek, E Kaya, EG Ümit, ... Turkish Journal of Hematology 38 (4), 273, 2021 | 2 | 2021 |
| Strain imaging by speckle tracking for the assessment of diastolic dysfunction in beta-thalassemia major patients M Okay, C Coteli, S Unal, T Hazırolan, E Karabulut, N Ozer, F Gumruk, ... Acta Medica 52 (1), 57-61, 2021 | 2 | 2021 |
| Tumor lysis syndrome due to targeting of hepatocellular carcinoma associated with chronic myelomonocytic leukemia M Okay, S Cetik, İ HAZNEDAROĞLU Turkish Journal of Hematology 36 (3), 2019 | 2 | 2019 |
| Clonal B‐cell proliferations developing in the background of primary cutaneous CD4+ small/medium T‐cell lymphoproliferative disorder: A case series D Ates Ozdemir, N Akdoğan, M Okay, A Uner, A Saglam Journal of Cutaneous Pathology 49 (11), 971-977, 2022 | 1 | 2022 |
nilgün sayinalpHacettepe UniversityVerified email at hacettepe.edu.tr
